Who to call at Lipella Pharmaceuticals Inc., and when
Fundz watches for the moments Lipella Pharmaceuticals Inc. starts buying, and tells you who to reach.
- An alert the day Lipella Pharmaceuticals Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lipella Pharmaceuticals Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lipella Pharmaceuticals Inc.. With Fundz connected, it knows.
Lipella Pharmaceuticals Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
lipella.comAI Executive Summary
AI-powered analysis of 8-K filing content
Lipella Pharmaceuticals director Naoki Yoshimura notified the company on October 20, 2025 that he will retire from the Board of Directors effective December 31, 2025. The filing states the decision did not result from any disagreement with the company on its operations, policies, or practices.
Key Takeaways
Dr. Naoki Yoshimura will leave Lipella's Board of Directors effective December 31, 2025, giving the company roughly two months of notice.
The filing states the retirement was not caused by any disagreement with the company on operations, policies, or practices, which lowers the likelihood of an underlying governance dispute.
2 more takeaways
Related Filings (3)
3 more filings from Lipella Pharmaceuticals Inc. in the last 90 days
Filing Overview
What This Means
Lipella Pharmaceuticals Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.